Camrelizumab combined with apatinib plus irinotecan as a second-line treatment in advanced or metastatic esophageal squamous cell carcinoma patients by Shusheng Wu, Huiqin Luo, Wenju Chen, Xudong Liu, Huimin Li, Mengge Li, Lihong Ke, Jiayu Niu, Bing Hu, Huijun Xu, Gang Wang, Ying Yan, Lulu Cao, Xiaoxiu Hu, Chenghui Li, Yifu He

Get full text

Homeobox protein MSX-1 restricts hepatitis B virus by promoting ubiquitin-independent proteasomal degradation of HBx protein. by Qian Qiu, Zihan He, Jing Liu, Huijun Xu, Jinyu Wang, Nannan Liu, Ning Kang, Shaokun Pan, Weien Yu, Zixiang Gao, Shimei Zhang, Yang Yang, Qiang Deng, Youhua Xie, Jiming Zhang, Zhongliang Shen

Get full text

Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia by Tingting Yang, Yetian Dong, Mingming Zhang, Jingjing Feng, Shan Fu, Pingnan Xiao, Ruimin Hong, Huijun Xu, Jiazhen Cui, Simao Huang, Guoqing Wei, Delin Kong, Jia Geng, Alex H. Chang, He Huang, Yongxian Hu

Get full text

Long-term follow-up of BCMA CAR-T cell therapy in patients with relapsed/refractory multiple myeloma by Yok-Lam Kwong, Tingting Yang, Guoqing Wei, He Huang, Zhen Cai, Mingming Zhang, Fengmei Song, Yongxian Hu, Yanlei Zhang, Simao Huang, Huijun Xu, Alex H Chang, Jingjing Feng, Jiazhen Cui, Chunxiang Jin, Rongrong Chen, Shan Fu, Yuanyin Teng, Ruimin Hong, Thomas Sau Yan Chan

Get full text